Unjha Formulations Ltd. logo

Unjha Formulations Ltd. (UNJHAFOR)

Market Closed
7 Aug, 22:00
MSE MSE
24. 25
+0.4
+1.6771%
94.05M Market Cap
34.98 P/E Ratio
- Div Yield
6,942 Volume
0 Eps
23.85
Previous Close
Add Transaction
Day Range
23.9 24.25
Year Range
17.52 29.5
Want to track UNJHAFOR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

UNJHAFOR closed Friday higher at ₹24.25, an increase of 1.6771% from Thursday's close, completing a monthly decrease of -16.9521% or -₹4.95. Over the past 12 months, UNJHAFOR stock lost -3%.
UNJHAFOR is not paying dividends to its shareholders.
The last earnings report, released on May 14, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

UNJHAFOR Chart

People also search for

Remedium Lifecare Ltd.
0.31
-3.125%
Supha Pharmachem Limited
0.31
-3.125%
Colinz Laboratories Ltd.
79.68
+0.0126%
Johnson Pharmacare Ltd.
0.48
+4.3478%
Bacil Pharma Ltd.
15.29
-4.972%

Unjha Formulations Ltd. (UNJHAFOR) FAQ

What is the stock price today?

The current price is ₹24.25.

On which exchange is it traded?

Unjha Formulations Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is UNJHAFOR.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 94.05M.

Has Unjha Formulations Ltd. ever had a stock split?

No, there has never been a stock split.

Unjha Formulations Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Ms. Krutiben Mayankkumar Patel CEO
MSE Exchange
INE576D01015 ISIN
India Country
14 Employees
- Last Dividend
- Last Split
- IPO Date
Unjha Formulations Ltd. is a pharmaceutical company that engages in the manufacturing and distribution of a broad range of pharmaceutical products. The company is primarily involved in producing formulations and healthcare solutions, catering to various therapeutic segments. With a focus on delivering quality, the company's product line spans across analgesics, antipyretics, cough and cold remedies, gastrointestinal agents, and several other categories aimed at maintaining and improving health. It plays a significant role in the healthcare sector, addressing the needs of patients and medical professionals alike. Unjha Formulations Ltd. makes its products available through a comprehensive network, ensuring their accessibility to both domestic and international markets. In the financial market, the company holds significance due to its contributions to the pharmaceutical industry, helping to meet ongoing healthcare challenges with effective treatment options.

Contact Information

Address: Khali Char Rasta
Phone: 91 27 6728 2395